Cerebellar rTMS ameliorates cognitive impairment in Alzheimer's disease: A randomized trial. | ClinicLens
Developing effective neuromodulatory therapies for Alzheimer's disease (AD) is a critical unmet need. While repetitive transcranial magnetic stimulation (rTMS) shows promise, its optimal targets and mechanisms remain incompletely understood. The cerebellum, a key modulator o
Medical Literature · Updated
← Back to articlesIf the embedded page does not load in your browser, open it directly.